phosphorylcholine has been researched along with deoxycholic acid in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 9 (64.29) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Chap, H; Douste-Blazy, L; Record, M; Tamer, AE | 1 |
| Bhat, MK; Goodenough, PW; Mueller-Harvey, I; Sumner, IG | 1 |
| Murray, HW | 1 |
| Boelaert, M; Diap, G; Gerstl, S; Guerin, PJ; Meheus, F; Van der Stuyft, P; Vanlerberghe, V | 1 |
| Bocanegra, R; Kirkpatrick, WR; Najvar, LK; Patterson, TF; Sorrell, TC; Wiederhold, NP | 1 |
| Campino, L; Henriques, S; Maia, C; Marques, M; Nunes, M; Rolão, N | 1 |
| Dong, H; Guo, K; Tu, M; Wu, M; Zeng, R; Zhao, J | 2 |
| Cappel, MA; Keeling, JH; Kevric, I | 1 |
| Coelho, AC; Espada, CR; Oliveira, JC; Reimão, JQ; Trinconi, CT; Uliana, SR | 1 |
| Amer, A; Asal, AM; Bekhit, AA; El-Faham, A; Guemei, AA; Haiba, NS; Khattab, SN | 1 |
| Al-Shargabi, TQ; Atta, KFM; Bekhit, AA; El Ashry, ESH; Farahat, OOM; Ibrahim, TM; Marei, MG | 1 |
| Fernando, SD; Rajapakse, S; Rodrigo, C; Weeratunga, P | 1 |
| Alves, F; Brack, M; Dahal, P; Guerin, PJ; Halleux, CM; Hawryszkiewycz, A; Maguire, BJ; Ngu, R; Olliaro, PL; Rashan, S; Singh-Phulgenda, S; Stepniewska, K | 1 |
4 review(s) available for phosphorylcholine and deoxycholic acid
| Article | Year |
|---|---|
Progress in the treatment of a neglected infectious disease: visceral leishmaniasis.
Topics: Amphotericin B; Antimony; Antiprotozoal Agents; Clinical Trials as Topic; Deoxycholic Acid; Drug Combinations; Drug Costs; Humans; Leishmaniasis, Visceral; Paromomycin; Phosphatidylcholines; Phosphatidylglycerols; Phosphorylcholine; Practice Guidelines as Topic | 2004 |
New World and Old World Leishmania Infections: A Practical Review.
Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Deoxycholic Acid; Drug Combinations; Humans; Incidence; Leishmania braziliensis; Leishmania donovani; Leishmania mexicana; Leishmania tropica; Leishmaniasis, Diffuse Cutaneous; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Phosphorylcholine; Polymerase Chain Reaction; Travel | 2015 |
Amphotericin B for treatment of visceral leishmaniasis: systematic review and meta-analysis of prospective comparative clinical studies including dose-ranging studies.
Topics: Amphotericin B; Antiprotozoal Agents; Clinical Trials as Topic; Deoxycholic Acid; Drug Combinations; Drug Compounding; Evidence-Based Medicine; Female; Humans; Leishmaniasis, Visceral; Male; Paromomycin; Phosphorylcholine; Survival Analysis; Treatment Outcome | 2018 |
Serious adverse events following treatment of visceral leishmaniasis: A systematic review and meta-analysis.
Topics: Amphotericin B; Antimony; Antiprotozoal Agents; Deoxycholic Acid; Drug Combinations; Humans; Leishmaniasis, Visceral; Phosphorylcholine | 2021 |
10 other study(ies) available for phosphorylcholine and deoxycholic acid
| Article | Year |
|---|---|
Turnover of phosphocholine and phosphoethanolamine in ether-phospholipids of Krebs II ascite cells.
Topics: Animals; Carcinoma, Krebs 2; Choline; Deoxycholic Acid; Ethanolamines; Glycerol; Kinetics; Mice; Phosphates; Phospholipids; Phosphorus Radioisotopes; Phosphorylcholine; Tritium | 1985 |
Simplified methods for the synthesis of 2-hexadecanoylthio-1-ethylphosphorylcholine and for the determination of phospholipase A2 activity.
Topics: Animals; Calcium Chloride; Deoxycholic Acid; Edetic Acid; Hydrogen-Ion Concentration; Kinetics; Lysophosphatidylcholines; Microchemistry; Octoxynol; Pancreas; Phospholipases A; Phospholipases A2; Phosphorylcholine; Polyethylene Glycols; Snake Venoms; Spectrophotometry; Swine; Temperature | 1993 |
Drug policy for visceral leishmaniasis: a cost-effectiveness analysis.
Topics: Amphotericin B; Antimony; Antiprotozoal Agents; Cost-Benefit Analysis; Decision Trees; Deoxycholic Acid; Drug Combinations; Endemic Diseases; Health Care Costs; Humans; Leishmaniasis, Visceral; Phosphorylcholine; Treatment Outcome | 2007 |
Limited activity of miltefosine in murine models of cryptococcal meningoencephalitis and disseminated cryptococcosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Deoxycholic Acid; Drug Combinations; Fluconazole; Meningitis, Cryptococcal; Meningoencephalitis; Mice; Microbial Sensitivity Tests; Phosphorylcholine; Survival | 2013 |
In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs.
Topics: Allopurinol; Amphotericin B; Animals; Antiprotozoal Agents; Deoxycholic Acid; Disease Reservoirs; Dog Diseases; Dogs; Drug Combinations; Humans; Immunocompetence; Immunocompromised Host; Inhibitory Concentration 50; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests; Phosphorylcholine | 2013 |
In vitro drug release and biological evaluation of biomimetic polymeric micelles self-assembled from amphiphilic deoxycholic acid-phosphorylcholine-chitosan conjugate.
Topics: Animals; Biomimetic Materials; Cell Survival; Chitosan; Deoxycholic Acid; Drug Carriers; Erythrocytes; Hemolysis; Mice; Micelles; NIH 3T3 Cells; Particle Size; Phosphorylcholine; Polymers; Quercetin; Rabbits; Spectrometry, Fluorescence | 2014 |
Self-assemblied nanocomplexes based on biomimetic amphiphilic chitosan derivatives for protein delivery.
Topics: Animals; Biomimetic Materials; Cattle; Chitosan; Deoxycholic Acid; Drug Carriers; Drug Liberation; Hemolysis; Hydrophobic and Hydrophilic Interactions; Mice; Nanoparticles; NIH 3T3 Cells; Phosphorylcholine; Rabbits; Serum Albumin, Bovine; Solvents | 2015 |
A Luciferase-Expressing Leishmania braziliensis Line That Leads to Sustained Skin Lesions in BALB/c Mice and Allows Monitoring of Miltefosine Treatment Outcome.
Topics: Amphotericin B; Animals; Antifungal Agents; Antiprotozoal Agents; Cricetinae; Deoxycholic Acid; Drug Combinations; Female; Gene Expression Regulation, Enzymologic; Leishmania braziliensis; Leishmaniasis, Cutaneous; Luciferases; Male; Mesocricetus; Mice; Mice, Inbred BALB C; Organisms, Genetically Modified; Phosphorylcholine; Time Factors | 2016 |
Study of antileishmanial activity of 2-aminobenzoyl amino acid hydrazides and their quinazoline derivatives.
Topics: Amino Acids; Amphotericin B; Antiprotozoal Agents; Deoxycholic Acid; Drug Combinations; Inhibitory Concentration 50; Isomerism; Leishmania; Magnetic Resonance Spectroscopy; Molecular Conformation; Phosphorylcholine; Quinazolines; Structure-Activity Relationship | 2017 |
Synthesis, modeling and biological evaluation of hybrids from pyrazolo[1,5c]pyrimidine as antileishmanial agents.
Topics: Amphotericin B; Antiprotozoal Agents; Binding Sites; Deoxycholic Acid; Drug Combinations; Drug Design; Humans; Leishmania major; Molecular Docking Simulation; Molecular Structure; Phosphorylcholine; Protein Binding; Pyrazoles; Pyrimidines; Structure-Activity Relationship | 2017 |